Macquarie Group Ltd. trimmed its stake in HealthSouth Corporation (NYSE:HLS) by 59.5% during the second quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 820,384 shares of the company’s stock after selling 1,204,422 shares during the period. Macquarie Group Ltd. owned 0.83% of HealthSouth Corporation worth $39,707,000 at the end of the most recent reporting period.
Other hedge funds also recently modified their holdings of the company. First Mercantile Trust Co. raised its stake in shares of HealthSouth Corporation by 18.8% in the 2nd quarter. First Mercantile Trust Co. now owns 2,720 shares of the company’s stock valued at $132,000 after acquiring an additional 430 shares in the last quarter. Acrospire Investment Management LLC raised its stake in shares of HealthSouth Corporation by 64.7% in the 2nd quarter. Acrospire Investment Management LLC now owns 2,800 shares of the company’s stock valued at $136,000 after acquiring an additional 1,100 shares in the last quarter. Advisor Group Inc. raised its stake in shares of HealthSouth Corporation by 33.8% in the 2nd quarter. Advisor Group Inc. now owns 3,092 shares of the company’s stock valued at $149,000 after acquiring an additional 781 shares in the last quarter. Petrus Trust Company LTA bought a new position in shares of HealthSouth Corporation in the 2nd quarter valued at approximately $210,000. Finally, HL Financial Services LLC bought a new position in shares of HealthSouth Corporation in the 2nd quarter valued at approximately $213,000. 93.04% of the stock is currently owned by institutional investors and hedge funds.
In other HealthSouth Corporation news, CEO Mark J. Tarr sold 22,625 shares of the company’s stock in a transaction that occurred on Monday, August 7th. The stock was sold at an average price of $43.00, for a total value of $972,875.00. Following the sale, the chief executive officer now owns 283,134 shares in the company, valued at $12,174,762. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 1.60% of the stock is owned by corporate insiders.
HealthSouth Corporation (NYSE HLS) opened at 46.50 on Friday. The firm has a 50-day moving average price of $44.95 and a 200 day moving average price of $45.22. The company has a market capitalization of $4.59 billion, a P/E ratio of 16.95 and a beta of 0.58. HealthSouth Corporation has a 12 month low of $36.97 and a 12 month high of $49.71.
HealthSouth Corporation (NYSE:HLS) last released its quarterly earnings data on Monday, July 31st. The company reported $0.71 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.68 by $0.03. The firm had revenue of $981.30 million for the quarter, compared to analyst estimates of $976.46 million. HealthSouth Corporation had a return on equity of 25.07% and a net margin of 6.70%. The business’s revenue for the quarter was up 6.6% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.69 earnings per share. Analysts expect that HealthSouth Corporation will post $2.71 EPS for the current year.
The firm also recently disclosed a quarterly dividend, which will be paid on Monday, October 16th. Shareholders of record on Monday, October 2nd will be paid a $0.25 dividend. This is a positive change from HealthSouth Corporation’s previous quarterly dividend of $0.24. The ex-dividend date of this dividend is Friday, September 29th. This represents a $1.00 annualized dividend and a yield of 2.15%. HealthSouth Corporation’s dividend payout ratio is currently 36.76%.
ILLEGAL ACTIVITY WARNING: This article was reported by Transcript Daily and is the property of of Transcript Daily. If you are reading this article on another domain, it was copied illegally and republished in violation of United States and international trademark and copyright law. The correct version of this article can be read at https://transcriptdaily.com/2017/10/08/healthsouth-corporation-hls-position-decreased-by-macquarie-group-ltd.html.
A number of research analysts recently weighed in on HLS shares. KeyCorp started coverage on HealthSouth Corporation in a research note on Thursday, June 15th. They issued a “sector weight” rating on the stock. ValuEngine downgraded HealthSouth Corporation from a “buy” rating to a “hold” rating in a research note on Friday, September 1st. Zacks Investment Research downgraded HealthSouth Corporation from a “buy” rating to a “hold” rating in a research note on Tuesday, August 15th. BidaskClub raised HealthSouth Corporation from a “sell” rating to a “hold” rating in a research note on Saturday, June 17th. Finally, Royal Bank Of Canada reissued a “buy” rating and issued a $53.00 price objective on shares of HealthSouth Corporation in a research note on Wednesday, July 5th. Three investment analysts have rated the stock with a sell rating, four have assigned a hold rating and three have given a buy rating to the company. The stock has a consensus rating of “Hold” and an average price target of $49.71.
HealthSouth Corporation Profile
HealthSouth Corporation (HealthSouth) is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. The Company manages its operations through segments, including inpatient rehabilitation, and home health and hospice.
Receive News & Ratings for HealthSouth Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthSouth Corporation and related companies with MarketBeat.com's FREE daily email newsletter.